Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach

Lees A, Tolosa E, Stocchi F, Ferreira JJ, Rascol O, Antonini A, Poewe W.

Expert Rev Neurother. 2023 Jan;23(1):15-24. doi: 10.1080/14737175.2023.2176220. Epub 2023 Feb 10.

Integrated Multimodal Omics and Dietary Approaches for the Management of Neurodegeneration

Murai T, Matsuda S.

Epigenomes. 2023 Sep 1;7(3):20. doi: 10.3390/epigenomes7030020.

In the Rat Midbrain, SG2NA and DJ-1 have Common Interactome, Including Mitochondrial Electron Transporters that are Comodulated Under Oxidative Stress

Bisoyi P, Ratna D, Kumar G, Mallick BN, Goswami SK.

Cell Mol Neurobiol. 2023 Oct;43(7):3061-3080. doi: 10.1007/s10571-023-01356-2. Epub 2023 May 10.

Effects of intensive speech treatment on Mandarin speakers with Parkinson's Disease: A review

Chen Q, Chen B, Wan Q, Wang Y, Li J, Huang Z.

Medicine (Baltimore). 2023 Feb 10;102(6):e32900. doi: 10.1097/MD.0000000000032900.

Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson's

J JB, Palathoti N, Dhanasekaran M, Sivasamy R, Ponnusankar S, Dhanabal SP, Sankar V, Justin A.

Neurol Sci. 2023 Jul;44(7):2265-2275. doi: 10.1007/s10072-023-06684-1. Epub 2023 Mar 4.

Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review

Hoxhaj P, Shah S, Muyolema Arce VE, Khan W, Sadeghzadegan A, Singh S, Collado GF, Goyal A, Khawaja I, Botlaguduru D, Razzaq W, Abdin ZU, Gupta I.

Cureus. 2023 May 11;15(5):e38907. doi: 10.7759/cureus.38907. eCollection 2023 May.

Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases

Yan SS, Campos de Souza S, Xie ZD, Bao YX.

Ibrain. 2023 Mar 5;9(2):214-230. doi: 10.1002/ibra.12095. eCollection 2023 Summer.

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease

Riederer P, Nagatsu T, Youdim MBH, Wulf M, Dijkstra JM, Sian-Huelsmann J.

J Neural Transm (Vienna). 2023 May;130(5):627-646. doi: 10.1007/s00702-023-02630-9. Epub 2023 Apr 16.

High-Mobility Group Box 1 (HMGB1) Protein in Parkinson's Disease Research: A 10-Year Bibliometric Analysis

Razali K, Mohamed WMY.

J Integr Neurosci. 2023 Jul 4;22(4):87. doi: 10.31083/j.jin2204087.

Utilization, surgical populations, centers, coverages, regional balance, and their influential factors of deep brain stimulation for Parkinson's disease: a large-scale multicenter cross-sectional study from 1997 to 2021

Meng F, Hu W, Wang S, Tam J, Gao Y, Zhu XL, Chan DTM, Poon WS, Poon TL, Cheung FC, Taw BBT, Li LF, Chen SY, Chan KM, Wang A, Xu Q, Han C, Bai Y, Wagle Shukla A, Ramirez-Zamora A, Lozano AM, Zhang J; DBS-PDCC collaborators.

Int J Surg. 2023 Nov 1;109(11):3322-3336. doi: 10.1097/JS9.0000000000000603.

Altered pathophysiology in common neurological conditions

Hill B, Peate I.

Br J Nurs. 2023 Nov 23;32(21):1032-1038. doi: 10.12968/bjon.2023.32.21.1032.

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy

Yeap YJ, Teddy TJW, Lee MJ, Goh M, Lim KL.

Int J Mol Sci. 2023 Jan 28;24(3):2523. doi: 10.3390/ijms24032523.

Rehabilitative interventions for impaired handwriting in people with Parkinson's disease: a scoping review

Gardoni A, Sarasso E, Agosta F, Filippi M, Corbetta D.

Neurol Sci. 2023 Aug;44(8):2667-2677. doi: 10.1007/s10072-023-06752-6. Epub 2023 Mar 25.

Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease

Nott A, Holtman IR.

Front Immunol. 2023 Jun 8;14:1168539. doi: 10.3389/fimmu.2023.1168539. eCollection 2023.

Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease

Buzoianu AD, Sharma A, Muresanu DF, Feng L, Huang H, Chen L, Tian ZR, Nozari A, Lafuente JV, Wiklund L, Sharma HS.

Adv Neurobiol. 2023;32:55-96. doi: 10.1007/978-3-031-32997-5_2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias